Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 7 The efficacy of phosphate-binder therapy

Published byAlexandra Mills Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 7 The efficacy of phosphate-binder therapy"— Presentation transcript:

1 Figure 7 The efficacy of phosphate-binder therapy
in patients with chronic kidney disease, including those on dialysis Figure 7 | The efficacy of phosphate-binder therapy in patients with chronic kidney disease, including those on dialysis. a | Data from placebo-controlled studies in populations without overt hyperphosphatemia do not support the use of any phosphate binder in the absence of hyperphosphataemia. b | In patients with hyperphosphataemia, only relative effects can be estimated owing to an absence of placebo-controlled data. The available studies suggest that non-calcium-based phosphate binders might be more beneficial than calcium-based phosphate binders. Vervloet, M. G. et al. (2016) The role of phosphate in kidney disease Nat. Rev. Nephrol. doi: /nrneph

Download ppt "Figure 7 The efficacy of phosphate-binder therapy"

Similar presentations

A.M. Thompson, T.G. Pickering  Kidney International 

A.M. Thompson, T.G. Pickering  Kidney International 
Figure 1 Disruption of phosphate homeostasis in chronic kidney disease (CKD) Figure 1 | Disruption of phosphate homeostasis in chronic kidney disease (CKD).

Figure 1 Disruption of phosphate homeostasis in chronic kidney disease (CKD) Figure 1 | Disruption of phosphate homeostasis in chronic kidney disease (CKD).
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.

Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.
Figure 4 Interplay between acute kidney injury (AKI),

Figure 4 Interplay between acute kidney injury (AKI),
Figure 6 Effects of adiponectin on podocyte function

Figure 6 Effects of adiponectin on podocyte function
Figure 5 Inter-relationships between sleep apnoea, CKD and brain injury Figure 5 | Inter-relationships between sleep apnoea, CKD and brain injury. In chronic.

Figure 5 Inter-relationships between sleep apnoea, CKD and brain injury Figure 5 | Inter-relationships between sleep apnoea, CKD and brain injury. In chronic.
Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease.

Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease.
Figure 6 Differences in glycaemic control with the study drug

Figure 6 Differences in glycaemic control with the study drug
Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.

Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.
Figure 4 Expression of coagulation protease receptors in renal cells

Figure 4 Expression of coagulation protease receptors in renal cells
Figure 4 Interactions between adipose, the microbiome and kidney

Figure 4 Interactions between adipose, the microbiome and kidney
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Mechanisms of kidney injury in the setting of obesity

Figure 1 Mechanisms of kidney injury in the setting of obesity
Figure 2 Physiological changes in the renal system in pregnancy

Figure 2 Physiological changes in the renal system in pregnancy
Figure 1 Types of coronary artery calcification

Figure 1 Types of coronary artery calcification
Figure 2 Proinflammatory mechanisms in CKD

Figure 2 Proinflammatory mechanisms in CKD
Figure 1 Role of the kidney in glucose homeostasis

Figure 1 Role of the kidney in glucose homeostasis
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Bhandari et al. Am J Nephrol 2017;45: (DOI: / )

Bhandari et al. Am J Nephrol 2017;45: (DOI: / )

Similar presentations

Ads by Google